GLP-1 RA medications found to be safe and effective for treating obesity in adults with mental illness

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in adults with severe mental illness, as well as having positive effects on mood, well-being, and quality of life in those both with and without mental illness, according to a systematic review of the available evidence being presented at the European Congress on Obesity (ECO) in Malaga, Spain (11–14 May).

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup